XM does not provide services to residents of the United States of America.
B
B

BancaMediolanum

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Italian private bank Banca Generali bids for broker Intermonte

UPDATE 2-Italian private bank Banca Generali bids for broker Intermonte Recasts, adds share reaction, deal rationale By Valentina Za and Cristina Carlevaro MILAN, Sept 16 (Reuters) - Italian private bank Banca Generali BGN.MI on Monday said it was launching a 98 million euro ($109 mln) all-cash buyout bid for Intermonte INTM.MI , to take the Milanese broker private and direct its services at Banca Generali clients.
A
B
B

Net inflows at Italian asset gatherers nearly double y-o-y in August

Net inflows at Italian asset gatherers nearly double y-o-y in August By Alessandro Parodi MILAN, Sept 9 (Reuters) - Italy's five listed asset gatherers reported for August combined net inflows of 1.5 billion euros ($1.7 billion), up from 783 million euros in the same month of 2023. Net inflows into more lucrative assets under management rose to a combined 1.02 billion euros, up from 295.4 million last year, data showed.
A
A
B
A
B
B

Banca Mediolanum Total Net Inflows In August At EUR 486 Mln

BRIEF-Banca Mediolanum Total Net Inflows In August At EUR 486 Mln Sept 6 (Reuters) - Banca Mediolanum SpA BMED.MI : TOTAL NET INFLOWS IN AUGUST AT EUR 486 MILLION Further company coverage: BMED.MI Reporting by Gdansk Newsroom
B

Italy - Factors to watch on August 26

Italy - Factors to watch on August 26 The following factors could affect Italian markets on Monday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury announces sale of BTP and CCTeu bonds, with relative amounts to be auctioned on Aug.
A
B
M
V
A
A
B
B
B
I
J
J
S
T
I
U

AstraZeneca, Beazley, Puma

EUROPE RESEARCH ROUNDUP-AstraZeneca, Beazley, Puma Aug 12 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AstraZeneca, Beazley and Puma on Monday. HIGHLIGHTS * AstraZeneca AZN.L : TD Cowen raises target price to 14,860p from 13,945p * Beazley BEZG.L : Jefferies raises target price to 1,020p from 975p * Puma SE PUMG.DE : Baader Helvea raises to buy from add * Quilter Plc QLT.L : Berenberg raises target price to 135p from 105p * WPP
A
B
B
B
D
D
E
H
J
J
L
L
M
M
O
P
S
S
U
V
W
A
A
B
B
R

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.